T-Cells Vaccine

Multiple sclerosis (MS) is just one example of the complex autoimmune diseases that can benefit from our T-cell vaccination (TCV) technology. This innovative method has the potential to revolutionise the treatment not only of autoimmune diseases but also of certain types of cancer.

 

The concept of T Cell Vaccination (TCV)

The core of this technology lies in immunisation with attenuated autoreactive T cells. These modified T cells are capable of inducing specific inhibition of autoimmune responses and, in some cases, tumour responses.

 

Customisation and Individualisation

Each vaccine is tailor-made for each patient. By taking the T cells responsible for the disease directly from the patient, we can create a vaccine that precisely targets the pathological mechanisms specific to each individual. This makes it a truly individualised and tailored approach.

 

Application to various diseases

Although TCV has been extensively studied in the context of MS, its potential application extends to a much wider range of diseases, including certain forms of cancer. T cells play a key role in regulating the immune response, which means that their modulation can have an impact on a variety of medical conditions.

 

Versatile mechanism of action

The modified T cells not only target autoimmune cells; they also have the potential to attack cancer cells. This versatility makes TCV particularly promising for a variety of patients suffering from conditions as diverse as MS, lupus and certain types of cancer.

 

Renewed Hope

With over 10 years of clinical use worldwide, TCV offers a new line of defence against debilitating and potentially fatal diseases. By addressing the underlying causes of these conditions, this method paves the way for more effective, longer-lasting and less invasive treatments.

 

Conclusion

Our T-cell vaccines offer an individualised and versatile therapeutic approach that has the potential to transform the landscape of treatment for autoimmune diseases and certain cancers. Talk to your healthcare team about whether this ground-breaking treatment option could be right for you.